PDE4-IN precursor

Overview

PDE4-IN precursor (Compound 10) is an orally active prodrug of phosphodiesterase 4 ( PDE4 ) inhibitor. PDE4-IN precursor undergoes enzymatic hydrolysis in the colon to release the active PDE4 inhibitor, which exerts local anti-inflammatory effects on the colonic mucosa. PDE4-IN precursor is applicable to research related to ulcerative colitis, Crohn's disease, and other relevant conditions.

Application

Products | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Crohn's Disease | Products > Disease Areas > Ulcerative Colitis | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Peptic Ulcer Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Others | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Phosphodiesterase (PDE) | Products > Signaling Pathways > Drug Intermediate

Product Information

• Catalog No.: HY-185172
• CAS No.: 2750575-21-2
• Molecular Formula: C32H36F2N2O10
• Molecular Weight: 646.63
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source